ValentinePR partnered with a clinical-stage biotech to translate complex data into clear, compliant messaging. Our team coordinated embargoed briefings with top trade and national outlets while aligning talking points with medical affairs.
The launch generated quality coverage and a pipeline of investor follow‑ups within the first week.